» Articles » PMID: 34766054

Role of Nanotechnology in Facing SARS-CoV-2 Pandemic: Solving Crux of the Matter with a Hopeful Arrow in the Quiver

Overview
Journal Sens Int
Date 2021 Nov 12
PMID 34766054
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense single-stranded RNA virus species with a zoonotic origin and responsible for the coronavirus disease 2019(COVID-19). This novel virus has an extremely high infectious rate, which occurs through the contact of contaminated surfaces and also by cough, sneeze, hand-to-mouth-to-eye contact with an affected person. The progression of infection, which goes beyond complications of pneumonia to affecting other physiological functions which cause gastrointestinal, Renal, and neurological complication makes this a life threatening condition. Intense efforts are going across the scientific community in elucidating various aspects of this virus, such as understanding the pathophysiology of the disease, molecular biology, and cellular pathways of viral replication. We hope that nanotechnology and material science can provide a significant contribution to tackle this problem through both diagnostic and therapeutic strategies. But the area is still in the budding phase, which needs urgent and significant attention. This review provides a brief idea regarding the various nanotechnological approaches reported for managing COVID-19 infection. The nanomaterials recently said to have good antiviral activities like Carbon nanotubes (CNTs) and quantum dots (QDs) were also discussed since they are also in the emerging stage of attaining research interest regarding antiviral applications.

Citing Articles

Nano-based techniques: A revolutionary approach to prevent covid-19 and enhancing human awareness.

Annamalai A, Karuppaiya V, Ezhumalai D, Cheruparambath P, Balakrishnan K, Venkatesan A J Drug Deliv Sci Technol. 2023; 86:104567.

PMID: 37313114 PMC: 10183109. DOI: 10.1016/j.jddst.2023.104567.


Recent Developments in Nanotechnology-Based Biosensors for the Diagnosis of Coronavirus.

Yadav S, Yadav R, Tabassum H, Arya M Plasmonics. 2023; 18(3):955-969.

PMID: 37229148 PMC: 10040920. DOI: 10.1007/s11468-023-01822-z.


Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19.

Yakoubi A, Dhafer C Plasmonics. 2023; 18(1):311-347.

PMID: 36588744 PMC: 9786532. DOI: 10.1007/s11468-022-01754-0.


Quantum dots against SARS-CoV-2: diagnostic and therapeutic potentials.

Rabiee N, Ahmadi S, Jamalipour Soufi G, Hekmatnia A, Khatami M, Fatahi Y J Chem Technol Biotechnol. 2022; 97(7):1640-1654.

PMID: 35463806 PMC: 9015521. DOI: 10.1002/jctb.7036.


Fabrication of chitosan-coated mixed spinel ferrite integrated with graphene oxide (GO) for magnetic extraction of viral RNA for potential detection of SARS-CoV-2.

Singh V, Batoo K, Singh M Appl Phys A Mater Sci Process. 2021; 127(12):960.

PMID: 34866806 PMC: 8627170. DOI: 10.1007/s00339-021-05067-7.


References
1.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y . Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020; 382(13):1199-1207. PMC: 7121484. DOI: 10.1056/NEJMoa2001316. View

2.
Sivasankarapillai V, Pillai A, Rahdar A, Sobha A, Das S, Mitropoulos A . On Facing the SARS-CoV-2 (COVID-19) with Combination of Nanomaterials and Medicine: Possible Strategies and First Challenges. Nanomaterials (Basel). 2020; 10(5). PMC: 7712148. DOI: 10.3390/nano10050852. View

3.
Wang J, Jiang M, Chen X, Montaner L . Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020; 108(1):17-41. PMC: 7323250. DOI: 10.1002/JLB.3COVR0520-272R. View

4.
Chen Y, Hsueh Y, Hsieh C, Tzou D, Chang P . Antiviral Activity of Graphene-Silver Nanocomposites against Non-Enveloped and Enveloped Viruses. Int J Environ Res Public Health. 2016; 13(4):430. PMC: 4847092. DOI: 10.3390/ijerph13040430. View

5.
Ransom E, Burnham C, Jones L, Kraft C, McDonald L, Reinink A . Fecal Microbiota Transplantations: Where Are We, Where Are We Going, and What Is the Role of the Clinical Laboratory?. Clin Chem. 2020; 66(4):512-517. DOI: 10.1093/clinchem/hvaa021. View